ClinicalTrials.gg
Active, not recruitingNCT07322107Updated Jan 7, 2026

Prefrontal Brain Activity and ECG Patterns in Stroke and Healthy Adults

An observational study in Stroke and Healthy Participants, sponsored by Pusan National University Yangsan Hospital. Active, not recruiting at 1 site in South Korea. Open to participants aged 19 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by Pusan National University Yangsan Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
45
Ages
19 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 279 studies in Stroke with a site in Korea, Republic of — 41 open to participants now, 49 under way, 2 of them phase 3. Stroke · Korea, Republic of.

Planned enrollment
56th of 61
45 · median 150
Started
2025
with 13 others
Observational
62 of 279
16 open now
Primary completion
2026-12
later than 27 of 48 live
Registered
266th of 279
by date
Lead sponsor
7 of 279
Pusan National University Yangsan Hospital

Among the 279 studies in Stroke with a site in Korea, Republic of, this one is the 56th largest by planned enrollment of the 61 observational ones that give a count, is one of 14 that started in 2025, is one of 62 observational ones, reaches primary completion later than 27 of the 48 other live ones, and was the 266th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

41 of the 279 studies in Stroke with a site in Korea, Republic of are open now. Recruiting first, the newest first:

36 more — sign in →

All 41 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 19 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 279 studies in Stroke with a site in Korea, Republic of, or all of them as a file.
02

Study summary

This observational study will evaluate brain activity and heart rhythm patterns in people with and without stroke. Brain activity will be measured using functional near-infrared spectroscopy (fNIRS) and electroencephalography (EEG), and cardiac activity will be measured using electrocardiography (ECG). The goal is to characterize differences in prefrontal brain activation and ECG features between stroke patients and healthy adults

Read the detailed description

This study is an observational investigation designed to characterize neurophysiological and cardiovascular features in adults with a history of stroke and in age-matched healthy controls. Participants will undergo noninvasive measurements of brain activity using functional near-infrared spectroscopy (fNIRS) and electroencephalography (EEG), focusing on prefrontal cortical responses during resting and simple task conditions. Electrocardiography (ECG) will be recorded concurrently to assess heart rate and rhythm characteristics, including temporal and spectral ECG parameters.

The primary objective is to compare patterns of prefrontal brain activation and ECG characteristics between stroke patients and healthy adults, exploring potential associations between altered cortical activity and cardiac autonomic regulation after stroke. Secondary aims include examining relationships between brain signals, ECG features, and clinical factors such as stroke severity or functional status in the patient group. Results from this study may help to generate hypotheses for future interventional research and to identify physiological markers useful for monitoring recovery or risk stratification in stroke survivors.

03

Conditions studied

  • Stroke
  • Healthy Participants

Browse trials for

Keywords

  • Stroke
  • Cerebral blood flow
  • Prefrontal cortex
  • Electroencephalography (EEG)
  • Functional near-infrared spectroscopy (fNIRS)
  • Electrocardiography (ECG)
  • Healthy Participants
04

Who can participate

Ages eligible
19 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults aged 19 to 80 years, including patients with intracerebral hemorrhage, patients with cerebral infarction, and neurologically healthy adult volunteers who meet the study's inclusion and exclusion criteria

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Intracerebral Hemorrhage Group (Stroke Patients)

Adults aged 19 to 80 years.

Diagnosed with intracerebral hemorrhage based on clinical evaluation and neuroimaging findings.

Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.

Voluntarily agrees to participate in the study, provides written , and is able to participate for the entire study period.

Cerebral Infarction Group (Stroke Patients)

Adults aged 19 to 80 years.

Diagnosed with cerebral infarction (ischemic stroke) based on clinical evaluation and neuroimaging findings.

Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.

Voluntarily agrees to participate in the study, provides written informed consent, and is able to participate for the entire study period.

Healthy Adult Group

Adults aged 19 to 80 years.

No history of stroke or (TIA).

No major stroke risk factors such as hypertension, diabetes mellitus, or hyperlipidemia.

No chronic diseases, including cardiovascular disease, chronic kidney disease, or chronic pulmonary disease.

No psychiatric disorders, such as depression or schizophrenia.

Not taking medications that may affect cerebral hemodynamics, including antihypertensive agents, anticoagulants, antiplatelet agents, or antidepressants.

Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.

Voluntarily agrees to participate in the study, provides written informed consent, and is able to participate for the entire study period.

Exclusion criteria

Exclusion Criteria:

  • Participants meeting any of the following exclusion criteria will not be enrolled in the study.

History of head trauma or cranial surgery within the past 6 months with wounds that have not yet fully healed.

Current diagnosis of a severe psychiatric disorder, such as schizophrenia, major depressive disorder, or bipolar disorder.

Participation in another clinical study and intake of an drug within the past 30 days.

Women who are pregnant or breastfeeding.

Presence of an acute infection or inflammatory disease.

Inability to adequately understand the study procedures or lack of voluntary consent to participate.

Any other finding that, in the judgment of the principal investigator or designated study physician, makes the individual unsuitable for participation in this study.

Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
45 participants (estimated)
Patient registry
No

Groups and cohorts

  • Intracerebral Hemorrhage (Stroke) Group

    Adults with a history of intracerebral hemorrhagic stroke. Participants undergo noninvasive measurements of prefrontal brain activity using fNIRS and EEG, and cardiac activity using ECG, to characterize neurophysiological and electrocardiographic features.

  • Cerebral Infarction (Stroke) Group

    Adults with a history of cerebral infarction (ischemic stroke). Participants receive the same fNIRS, EEG, and ECG assessments as the hemorrhagic stroke group to compare patterns of brain activation and ECG characteristics.

  • Healthy Adult Control Group

    Neurologically healthy adults without a history of stroke or major cardiovascular disease. Participants undergo identical fNIRS, EEG, and ECG measurements to serve as a comparison group for stroke patients.

06

What researchers measure

Primary outcomes

  1. Resting-State Prefrontal EEG Activity

    Quantitative characteristics of resting-state electroencephalographic (EEG) activity recorded from the prefrontal cortex (Fp1, Fp2, F7, F8) using a 10-20 electrode placement system during 10 minutes of eyes-closed rest. EEG is obtained once for each participant in one of three groups (intracerebral hemorrhage, cerebral infarction, healthy adults) within a 30-minute session including approximately 10 minutes of preparation, 10 minutes of recording, and 10 minutes of completion procedures.

    Time frame: Single assessment at one visit (approximately 30-minute session).

  2. Resting-State Prefrontal fNIRS Oxygenation

    Changes in oxy-hemoglobin and deoxy-hemoglobin concentrations in the prefrontal cortex (corresponding to Fp1, Fp2, F7, F8) measured by functional near-infrared spectroscopy (fNIRS) during 10 minutes of eyes-closed rest. fNIRS is performed once for each participant in the same 30-minute session (about 10 minutes preparation, 10 minutes recording, 10 minutes completion) in one of the three groups.

    Time frame: Single assessment at one visit (approximately 30-minute session).

  3. Resting-State Electrocardiographic Parameters

    Electrocardiographic (ECG) characteristics recorded for 10 minutes during eyes-closed rest, using electrodes attached to the ears and both wrists, including heart rate, rhythm, and time- and frequency-domain indices of heart rate variability. ECG is measured once for each participant during the same 30-minute session (around 10 minutes preparation, 10 minutes recording, 10 minutes completion) in one of the three groups.

    Time frame: Single assessment at one visit (approximately 30-minute session).

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) cannot be shared due to protection of participants' personal infand regulatory restrictions of our hospital.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Dec 2026, 13 months after the start.

Of 838 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 13 months is below that.

Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 23, 2025
First posted
Jan 7, 2026
StartActual
Nov 6, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Jan 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07322107
Responsible party
Yong-il Shin (Professor, Pusan National University Yangsan Hospital) — Principal investigator
First posted
Jan 7, 2026
Start date
Nov 6, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jan 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion